Think globally, act locally: Expert opinions from Asia on the diagnosis and treatment of pemphigus vulgaris

Indian Journal of Medical Sciences

Volumn 61, Issue 3, 2007, Pages 144-151

  Samadi, Zeynab ^a   Gorouhi, Farzam ^a   Davari, Parastoo ^a   Firooz, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Corticosteroids; Diagnosis; Immunosuppressors; Pemphigus; Therapy

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DEXAMETHASONE; GOLD; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TETRACYCLINE;

ADD ON THERAPY; ARTICLE; ASIA; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; E-MAIL; HEALTH SURVEY; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL EXPERT; MEDICAL SPECIALIST; PEMPHIGUS VULGARIS; POSTAL MAIL; PUBLIC OPINION; QUESTIONNAIRE;

EID: 33847788991     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.30749     Document Type: Article

References (24)

1. Chams-Davatchi C, Valikhani M, Daneshpazhooh M, Esmaili N, Balighi K, Hallaji Z, et al. Pemphigus: Analysis of 1209 cases. Int J Dermatol 2005;44:470-6.
2. Salmanpour R, Shahkar H, Namazi MR, Rahman-Shenas MR. Epidemiology of pemphigus in southwestern Iran: A 10-year retrospective study (1991-2000). Int J Dermatol 2006;45:103-5.
3. Shamsadini S, Fekri AR, Esfandiarpoor I, Saryazdi S, Rahnama Z, Zandi S, et al. Determination of survival and hazard functions for pemphigus patients in Kerman, a southern province of Iran. Int J Dermatol 2006;45:668-71.
4. Asilian A, Yoosefi A, Faghini G. Pemphigus vulgaris in Iran: Epidemiology and clinical profile. Skinmed 2006;5:69-71.
5. Hietanen J, Salo OP. Pemphigus: An epidemiological study of patients treated in Finnish hospitals between 1969 and 1978. Acta Derm Venereol 1982;62:491-6.
6. Haouet H, Ben Hamida A, Haouet S, Chaffai M, Ben Osman A. Tunisian pemphigus. Apropos of 70 cases. (Experience of the dermatology department of La Rabta Hospital 1974-92). Ann Dermatol Venereol 1996;123:9-11.
7. Nanda A, Dvorak R, Al-Saeed K, Al-Sabah H, Alsaleh QA. Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol 2004;43:876-81.
8. Hafeez ZH. Pemphigus in Pakistan, A study of 108 cases. J Pak Med Assoc 1998;48:9-10.
9. Uzun S, Durdu M, Akman A, Gunasti S, Uslular C, Memisoglu HR, et al. Pemphigus in the Mediterranean region of Turkey: A study of 148 cases. Int J Dermatol 2006;45:523-8.
10. Pisanti S, Sharav Y, Kaufman E, Posner LN. Pemphigus vulgaris: Incidence in Jews of different ethnic groups, according to age, sex and initial lesion. Oral Surg Oral Med Oral Pathol 1974;38:382-7.
11. Naldi L, Bertoni M, Cainelli T. Feasibility of a registry of pemphigus in Italy: Two years experience. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Int J Dermatol 1993;32:424-7.
12. Bastuji-Garin S, Souissi R, Blum L, Turki H, Nouira R, Jomaa B, et al. Comparative epidemiology of pemphigus in Tunisia and France. Incidence of foliaceus pemphigus in young Tunisian women. Ann Dermatol Venereol 1996;123:337-42.
13. Wilson C, Wojnarowska F, Mehra NK, Pasricha JS. Pemphigus in Oxford, UK and New Delhi, India: A comparative study of disease characteristics and HLA antigens. Dermatology 1994;189:108-10.
14. Alhashimi M, Pittelkow M. Epidemiology of pemphigus in Olmsted County, Minnesota from 1950-2000. J Am Acad Dermatol 2005;53:104.
15. Mobini N, Yunis EJ, Alper CA, Yunis JJ, Delgado JC, Yunis DE, et al. Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: Possible common central Asian ancestral origin. Hum Immunol 1997;57:62-7.
16. Mimouni D, Nousari CH, Cummins DL, Kouba DJ, David M, Anhalt GJ. Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris. J Am Acad Dermatol 2003;49:1059-62.
17. Pasricha JS, Khaitan BK, Raman RS, Chandra M. Dexamethasone- cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995;34:875-82.
18. Kanwar AJ, Kaur S, Thami GP. Long-term efficacy of dexamethasone- cyclophosphamide pulse therapy in pemphigus. Dermatology 2002;204:228-31.
19. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005;366:61-73.
20. Chams-Davatchi C, Daneshpazhooh M. Prednisolone dosage in pemphigus vulgaris. J Am Acad Dermatol 2005;53:547.
21. Enk AH, Knop J. Mycophenolate mofetil is effective in the treatment of pemphigus vulgaris. Arch Dermatol 1999;135:54-6.
22. Fleischli ME, Valek RH, Pandya AG. Pulse intravenous cyclophosphamide therapy in pemphigus. Arch Dermatol 1999;135:57-61.
23. Mentink LF, Mackenzie MW, Toth GG, Laseur M, Lambert FP, Veeger NJ, et al. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial. Arch Dermatol 2006;142:570-6.
24. Beissert S, Werfel T, Frieling U, Bohm M, Sticherling M, Stadler R, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol 2006;142:1447-54.